文献速递膀胱癌与上尿路尿路上皮癌

膀胱EpiCheck触发光动力诊断活检可检出白光膀胱镜漏诊的高级别膀胱癌复发

Bladder EpiCheck triggered Photodynamic Diagnosis biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy.
PubMed 文献 · Eur Urol Oncol · 2025-11-27

本研究在高危非肌层浸润性膀胱癌监测中,比较白光膀胱镜(WLC)与膀胱EpiCheck(BE)以光动力诊断(PDD)引导活检为基准的诊断准确性。315次监测中,BE对病理确认复发的检出率92%显著高于WLC的62%,对高级别复发检出率90%对63%,且BE阳性而WLC阴性者行PDD引导活检可提高BE特异度和阳性预测值。

要点

  • BE对高级别复发的检出率90%显著高于WLC的63%。
  • WLC漏诊而BE检出的高级别癌中73%为原位癌。
  • BE阳性而WLC阴性者行PDD引导活检可提高BE特异度和阳性预测值。

核心结论

  • 在高级别NMIBC监测中,BE联合WLC并对BE阳性者行PDD引导活检可显著提高高级别复发的检出,利于早期干预并可能保留膀胱。

研究设计与样本

  • NHS质量改进项目中的前瞻性、非随机、无对照研究,纳入2023年7月至2024年8月在一家三级中心监测的适合全麻的高级别NMIBC连续患者,所有患者均接受WLC和BE检查。

主要发现

  • 315次监测 visits 中,37例病理确认复发,WLC检出23例(62%,95%CI 46-76%),BE检出34例(92%,95%CI 79-97%),p=0.0074。
  • 30例高级别复发中,WLC检出19例(63%,95%CI 46-78%),BE检出27例(90%,95%CI 74-97%),p=0.0386。
  • WLC漏诊而BE检出的高级别癌中73%为Tis。
  • 对WLC阴性BE阳性者行PDD引导活检,BE特异度从87%(95%CI 82-90%)提高至93%(95%CI 89-96%),阳性预测值从35%(95%CI 24-48%)提高至57%(95%CI 44-68%)@6个月,长期随访达70%(95%CI 58-80%)。

临床怎么用

  • 在高级别NMIBC监测中,可考虑将BE与WLC联合使用,并对BE阳性而WLC阴性的患者行PDD引导活检以检出WLC漏诊的高级别复发。

局限性

  • 非随机设置且缺乏对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: White light cystoscopy (WLC) misses ∼70% of carcinoma in situ bladder recurrences that could be identified via photodynamic diagnosis (PDD). The Bladder EpiCheck (BE) test has high sensitivity and specificity, with a recognised anticipatory positive signal. Our aim was to determine the diagnostic accuracy of BE and WLC against PDD-guided biopsy as the diagnostic benchmark during surveillance for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). METHODS: As part of a National Health Service (NHS) quality improvement project, all consecutive patients with HG-NMIBC who were fit for general anaesthesia and on surveillance in a tertiary centre underwent both WLC and BE from July 2023 to August 2024. Data were prospectively collected. Voided urine was collected before WLC for BE testing. Positive WLC and/or BE results triggered PDD-guided biopsy/resection under general anaesthesia. Performance metrics for WLC and BE were calculated on the basis of biopsies performed within 6 mo of a surveillance visit. KEY FINDINGS AND LIMITATIONS: Valid BE results were available for 315 HG-NMIBC surveillance visits. Of the 37 pathologically confirmed recurrences, 23 (62%, 95% confidence interval [CI] 46-76%) were detected by WLC and 34 (92%, 95% CI 79-97%) by BE (p = 0.0074). Of the 30 HG recurrences, 19 (63%, 95% CI 46-78%) were detected by WLC and 27 (90%, 95% CI 74-97%) by BE (p = 0.0386). Most of the HG cancers missed by WLC and detected by BE (73%) were Tis. Performing PDD-guided biopsies for patients with negative WLC and positive BE results increased the BE specificity from 87% (95% CI 82-90%) to 93% (95% CI 89-96%), and the positive predictive value from 35% (95% CI 24-48%) to 57% (95% CI 44-68%) at 6 mo, and to 70% (95% CI 58-80%) at longer-term follow-up. The main limitations are the nonrandomised setting and the lack of a control group. CONCLUSIONS AND CLINICAL IMPLICATIONS: BE addition to WLC, with PDD-guided biopsy performed for BE-positive cases, reveals the true performance of BE and WLC and significantly improves the detection of HG disease, allowing earlier intervention with potentially bladder-sparing options.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Mariappan P, Hart-Brooke J, Sparks R, et al. Bladder EpiCheck triggered Photodynamic Diagnosis biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy. Eur Urol Oncol. 2025. PMID: 41314886. doi:10.1016/j.euo.2025.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。